Related Experiment Video
Updated: Jun 14, 2026
07:09
Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
Interaction of nerve agent antidotes with cholinergic systems.
1Department of Toxicology, Faculty of Military Health Science, University of Defense Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. soukup.ondrej@seznam.cz
Current Medicinal Chemistry
|March 30, 2010
Summary
Organophosphorus poisoning is a severe threat. This review explores treatments, focusing on oximes which may offer benefits beyond acetylcholinesterase reactivation by interacting with cholinergic receptors.
Area of Science:
- Toxicology
- Pharmacology
- Neuroscience
Background:
- Organophosphorus compound poisoning poses a significant, life-threatening risk, exacerbated by potential terroristic threats.
- Current therapeutic strategies lack a universal antidote, necessitating research into novel treatment approaches.
- Understanding the cholinergic system, receptors, and cholinesterases is crucial for developing effective countermeasures.
Purpose of the Study:
- To review the properties and effects of organophosphorus nerve agents.
- To discuss current and emerging therapeutic strategies for organophosphorus poisoning.
- To investigate the non-cholinesterase-related antidotal mechanisms of oximes.
Main Methods:
- Literature review of organophosphorus compounds, cholinergic system, and antidotal therapies.
- Analysis of traditional oxime therapies targeting acetylcholinesterase reactivation.
- Exploration of alternative oxime mechanisms, including interactions with muscarinic and nicotinic receptors.
Main Results:
- Organophosphorus nerve agents present a severe toxicological challenge.
- Traditional oxime therapy focuses on acetylcholinesterase reactivation.
- Oximes demonstrate potential non-cholinesterase-coupled antidotal effects via receptor interactions.
Conclusions:
- Effective treatment for organophosphorus poisoning requires a comprehensive understanding of the cholinergic system.
- Oximes offer a promising therapeutic avenue, with potential benefits extending beyond enzyme reactivation.
- Further research into oxime interactions with cholinergic receptors may lead to improved treatment protocols.
More Related Videos
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...